Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
RaySearch Laboratories AB is a medical technology company based in Sweden that specializes in software solutions for radiation therapy used in cancer treatment. The company's primary product is RayStation, an advanced treatment planning system that integrates a comprehensive set of tools for creating radiation therapy plans. Founded in 2000, RaySearch focuses heavily on research and development to innovate in adaptive therapy, automated planning, and machine learning. Its strategic partnerships with major equipment vendors expand its geographic presence, serving clinics and hospitals worldwide. The company's competitive strength lies in its advanced algorithms and focus on improving patient outcomes and treatment workflows.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
RaySearch Laboratories ABEli Lilly
Last price
kr 202.80$1,417.54
Currency
SEK
USD
kr 6.8B$1.3T
32.5646.01
kr 6.23$30.81
0.870.45
kr 4.00$6.69
1.97%0.49%
Sector
HealthHealth
Employees
46450,000
Ticker
Skr RAY B$LLY
Primary listing
XSTONYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in SkrRAY B or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.